Qiagen N.V. announced the introduction of more than 170 new QIAseq Targeted RNA Panels for gene expression profiling, expanding Qiagen’s portfolio of Sample to Insight solutions for next-generation sequencing (NGS). The panels enable researchers to select from over 20,000 human genes and lncRNA to survey expression fold changes and discover interactions between genes, cellular phenotypes and disease processes.
{iframe}http://www.pharmabiz.com/NewsDetails.aspx?aid=93449&sid=2{/iframe}